For each trial, there are a small percentage of patients who have complete, partial, or mixed response to the vaccine. Others show a stabilization of the disease where deterioration of condition would be expected. As traditional treatments were often unsuccessful with these patients, these results are significant. However, the very low rate of success underscores the complexity of the human immune system, the number of variables in the
vaccine method, and the amount of research that will need to be done to develop an effective vaccine treatment for this disease.
Restifo, Nicholas, et al. "Therapeutic Cancer Vaccines." InCancer Principles & Practice of Oncology, edited by DeVita, Vincent T., et al. Philadelphia: LippincottWilliams & Wilkins, 2001, pp. 3195-217.
Bocchia, Monica, et al. "Antitumor Vaccination: Where WeStand." Haematologica 85 (November 2000): 1172-206.
Monzavi-Karbassi, B., and T. Kieber-Emmons. "Current concepts in cancer vaccine strategies." Biotechniques 30 (January 2001): 170.
"First Potential Universal Cancer Vaccine Shows Promise InLab." Science Daily Magazine. 30 August 2000. 12 April 2001. 28 June 2001 <http://www.sciencedaily.com/print/2000/08/000830073711.htm>.